1. Home
  2. RZLV vs ABCL Comparison

RZLV vs ABCL Comparison

Compare RZLV & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLV
  • ABCL
  • Stock Information
  • Founded
  • RZLV 2016
  • ABCL 2012
  • Country
  • RZLV United Kingdom
  • ABCL Canada
  • Employees
  • RZLV N/A
  • ABCL N/A
  • Industry
  • RZLV
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • RZLV
  • ABCL Health Care
  • Exchange
  • RZLV NYSE
  • ABCL Nasdaq
  • Market Cap
  • RZLV 697.4M
  • ABCL 772.9M
  • IPO Year
  • RZLV N/A
  • ABCL 2020
  • Fundamental
  • Price
  • RZLV $2.03
  • ABCL $2.03
  • Analyst Decision
  • RZLV Strong Buy
  • ABCL Buy
  • Analyst Count
  • RZLV 5
  • ABCL 3
  • Target Price
  • RZLV $5.20
  • ABCL $7.50
  • AVG Volume (30 Days)
  • RZLV 5.9M
  • ABCL 4.0M
  • Earning Date
  • RZLV 02-21-2025
  • ABCL 05-08-2025
  • Dividend Yield
  • RZLV N/A
  • ABCL N/A
  • EPS Growth
  • RZLV N/A
  • ABCL N/A
  • EPS
  • RZLV N/A
  • ABCL N/A
  • Revenue
  • RZLV $187,788.00
  • ABCL $23,114,000.00
  • Revenue This Year
  • RZLV $18,130.13
  • ABCL N/A
  • Revenue Next Year
  • RZLV $184.28
  • ABCL $36.62
  • P/E Ratio
  • RZLV N/A
  • ABCL N/A
  • Revenue Growth
  • RZLV 29.46
  • ABCL N/A
  • 52 Week Low
  • RZLV $1.07
  • ABCL $1.89
  • 52 Week High
  • RZLV $14.50
  • ABCL $4.34
  • Technical
  • Relative Strength Index (RSI)
  • RZLV N/A
  • ABCL 34.87
  • Support Level
  • RZLV N/A
  • ABCL $1.98
  • Resistance Level
  • RZLV N/A
  • ABCL $2.64
  • Average True Range (ATR)
  • RZLV 0.00
  • ABCL 0.14
  • MACD
  • RZLV 0.00
  • ABCL -0.06
  • Stochastic Oscillator
  • RZLV 0.00
  • ABCL 7.14

About RZLV REZOLVE AI LTD

Rezolve AI Ltd provides a mobile commerce and engagement platform, underpinned by machine learning, that enables retailers, brands and manufacturers to engage with consumers in a broad range of locations and settings via their mobile devices and personal computers. its platform allows for mobile engagement with merchants using its software to extend their business to consumers' mobile devices and computers in different ways.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: